Associate Biotech VC | PhD in Stem Cell Biology & Medicine from @Cambridge_Uni
Joined June 2020
- Tweets41
- Following310
- Followers57
- Likes194
Daniel Bode retweeted
We are hiring!!🚀🚀 Great experience working with a very cool microfluidic tech #ForCell and gaining expertise in blood stem research!! If you are self-motivated and enthusiastic research scientist/engineer, we want to hear from you
@CBR_UoY Forcell.co
#JOB🚨 for a research technician with @rasharezk_ within @BiologyatYork conducting cutting-edge research on blood stem cells using microfluidics technology. Apply by 20/8/24 jobs.york.ac.uk/vacancy/rese…
Daniel Bode retweeted
Postdoc @MJassinskaja and @BBSRCWhiteRose PhD student Monika Gonka pull together a top rate summary of the tools that try to link molecular profile with cell function
Now online @BloodJournal first edition
#HSCs #hematology
ashpublications.org/blood/ar…
@YBRI_UoY @BiologyatYork
Daniel Bode retweeted
Share as widely as possible please.
This programme has been a real game changer in the Department for widening access to fully paid research opportunities.
Also - consider donating/partnering to help them expand in future.
yustart.hubbub.net/p/generat…
Applications for #GenerationResearch summer studentships are now open! ✨
Please encourage students to head to our new webpage bit.ly/3wdnas7 to check the projects for eligibility criteria and apply.
US deadline: 21 Feb, UK deadline: 28 Feb
ALT GenerationResearch logo top left, 'Applications are now open'. Dark green background. Generationresearch.ac.uk
Daniel Bode retweeted
Congratulations Ali @erturklab, Matthias @labs_mann, Fabian @fabian_theis and teams for this tour de force study, brilliant!
cell.com/cell/fulltext/S0092…
Daniel Bode retweeted
*Looking for a part-time researcher to join the @CompoundVC squad* 🚀
The researcher will be working directly with me on due diligence and on building out new theses ✨More info below 🤓
Send apps to shelby@compound.vc
Daniel Bode retweeted
Good things come in bunches! Well done to @Bode_Dan and @jimseeche for this @emboreports paper that identifies and characterises in vitro expanded HSCs from conditions developed by @awilkinsongroup, Reiko Ishida, Hiro Nakauchi, Satoshi Yamazaki and co.
embopress.org/doi/full/10.15…
Daniel Bode retweeted
It's time to stop making t-SNE & UMAP plots. In a new preprint w/ Tara Chari we show that while they display some correlation with the underlying high-dimension data, they don't preserve local or global structure & are misleading. They're also arbitrary.🧵biorxiv.org/content/10.1101/…
Daniel Bode retweeted
"they forget everything.. the battles you fought alone, lost and won, all those sleepless nights, misspent summers.. they just remember that one and a half figure panel and your last name.."
Daniel Bode retweeted
Out now as a Resource Article in @NatureNeuro: A database and deep learning toolbox for spike inference from calcium imaging: rdcu.be/creIt
With @RainerFriedri12 and @FritjofHelmchen, @HoffmannNeuro, @kazkitamura, @SonjaBHofer, @ant_blot, @kwanalexc and others.
Daniel Bode retweeted
Updated preprint on BioRxiv on how NuRD impacts enhancer dynamics! Wonder if other chromatin remodellers act the same… #chromatin #CTCF #stemcells #enhancers #3dgenome (Some highlights below) biorxiv.org/content/10.1101/…
Daniel Bode retweeted
A PI doesn't get many happy emails, Most emails are things you need to take care of (or rejections). So if a PI wrote you a reference & you got the award or accepted to your dream program please please please don't forget to send them an email telling them. It will make their day
Daniel Bode retweeted
My favourite outcome of the AlphaFold2 depository is likely unintended - it finally gives visuals to the possible extent of protein disorder in the proteome. Browsing the PDB suggests all is helices and sheets, whereas with these full-length models a different picture emerges.
Daniel Bode retweeted
New Research: Exploiting Single-Cell Tools in Gene and Cell Therapy: Single-cell molecular tools have been developed at an incredible pace over the last five years as sequencing costs continue to drop and numerous molecular assays have been… frontiersin.org/articles/10.… #immunology
Gene and Cell therapies are entering the clinic, but their full potential is yet to be unlocked - Single-cell multiomics can play a crucial role in achieving that goal! Our review below outlines how single-cell tools can help: frontiersin.org/articles/10.…
Daniel Bode retweeted
Today we published our paper in @NatureBiotech describing novel C to G base editors (CGBEs). This project started in my first year of graduate school and took a bit to get across the finish line. We started making CGBEs by taking advantage of an observation that C to T...
Daniel Bode retweeted
Application deadline extended until 7/7/21! Looking for two postdoctoral scientists to join the lab with interests in cell and molecular biology and experience in haematology/cytokines/immunology/cancer.
Happy to chat with anyone who's interested!
tinyurl.com/yr8hjd8m
Daniel Bode retweeted
What's that you say? A "real job" in biomedical science?
@BiologyatYork is now #hiring a #Lecturer/Senior Lecturer in Biomedical Science. Keen to hear from a wide-range of applicants (Departmental #AthenaSwan Gold award)
Please retweet and get in touch if interested!
We are extremely delighted to share our latest work, describing a new system for identifying functional blood stem cells in culture! Great team effort by all authors, particularly @jimseeche and @scienceadvocacy! Check here: biorxiv.org/content/10.1101/…
